A citation-based method for searching scientific literature

Dong-Yan Zhao, Xi-Zhen Sun, Shu-Kun Yao. World J Gastrointest Oncol 2021
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Tertiary lymphoid structures in cancer - considerations for patient prognosis.
Luis Munoz-Erazo, Janet L Rhodes, Valentine C Marion, Roslyn A Kemp. Cell Mol Immunol 2020
16
50

Prognostic Biomarker TP53 Mutations for Immune Checkpoint Blockade Therapy and Its Association With Tumor Microenvironment of Lung Adenocarcinoma.
Xinqing Lin, Liqiang Wang, Xiaohong Xie, Yinyin Qin, Zhanhong Xie, Ming Ouyang, Chengzhi Zhou. Front Mol Biosci 2020
3
50

MiRNA expression patterns are associated with tumor mutational burden in lung adenocarcinoma.
Yufeng Lv, Zhong Huang, Yan Lin, Yuan Fang, Zhichao Chen, Lili Pan, Yanxian Zhang, Zihai Xu. Oncoimmunology 2019
12
50

Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma.
Hao Sun, Si-Yang Liu, Jia-Ying Zhou, Jin-Tian Xu, Huang-Kai Zhang, Hong-Hong Yan, Jiao-Jiao Huan, Ping-Ping Dai, Chong-Rui Xu, Jian Su,[...]. EBioMedicine 2020
12
50

Embryonic FAP+ lymphoid tissue organizer cells generate the reticular network of adult lymph nodes.
Alice E Denton, Edward J Carr, Lukasz P Magiera, Andrew J B Watts, Douglas T Fearon. J Exp Med 2019
25
50

Pan-cancer analysis of genomic properties and clinical outcome associated with tumor tertiary lymphoid structure.
Ziying Lin, Lixia Huang, ShaoLi Li, Jincui Gu, Xiaoxian Cui, Yanbin Zhou. Sci Rep 2020
6
50

Immunotherapy converts nonimmunogenic pancreatic tumors into immunogenic foci of immune regulation.
Eric R Lutz, Annie A Wu, Elaine Bigelow, Rajni Sharma, Guanglan Mo, Kevin Soares, Sara Solt, Alvin Dorman, Anthony Wamwea, Allison Yager,[...]. Cancer Immunol Res 2014
271
50

Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures.
Marie-Caroline Dieu-Nosjean, Martine Antoine, Claire Danel, Didier Heudes, Marie Wislez, Virginie Poulot, Nathalie Rabbe, Ludivine Laurans, Eric Tartour, Luc de Chaisemartin,[...]. J Clin Oncol 2008
538
50

KRAS-Driven Lung Adenocarcinoma and B Cell Infiltration: Novel Insights for Immunotherapy.
Rosamaria Pinto, Daniela Petriella, Rosanna Lacalamita, Michele Montrone, Annamaria Catino, Pamela Pizzutilo, Maria Antonietta Botticella, Francesco Alfredo Zito, Gabriella Del Bene, Antonia Zonno,[...]. Cancers (Basel) 2019
17
50


Vitamin D3 Metabolites Demonstrate Prognostic Value in EGFR-Mutant Lung Adenocarcinoma and Can be Deployed to Oppose Acquired Therapeutic Resistance.
Tatiana Shaurova, Grace K Dy, Sebastiano Battaglia, Alan Hutson, Letian Zhang, Yunkai Zhang, Christine M Lovly, Mukund Seshadri, David W Goodrich, Candace S Johnson,[...]. Cancers (Basel) 2020
3
50

Circulating PD-L1 in NSCLC patients and the correlation between the level of PD-L1 expression and the clinical characteristics.
Jie Zhang, Jing Gao, Yanyan Li, Jun Nie, Ling Dai, Weiheng Hu, Xiaoling Chen, Jindi Han, Xiangjuan Ma, Guangming Tian,[...]. Thorac Cancer 2015
72
50

PD-L1 expression in advanced NSCLC: Insights into risk stratification and treatment selection from a systematic literature review.
Robert Brody, Yiduo Zhang, Marc Ballas, Mohd Kashif Siddiqui, Palvi Gupta, Craig Barker, Anita Midha, Jill Walker. Lung Cancer 2017
102
50

Multiomics analysis on DNA methylation and the expression of both messenger RNA and microRNA in lung adenocarcinoma.
Zhaoyang Yang, Bao Liu, Tie Lin, Yingli Zhang, Limin Zhang, Meng Wang. J Cell Physiol 2019
11
50

B cells and tertiary lymphoid structures promote immunotherapy response.
Beth A Helmink, Sangeetha M Reddy, Jianjun Gao, Shaojun Zhang, Rafet Basar, Rohit Thakur, Keren Yizhak, Moshe Sade-Feldman, Jorge Blando, Guangchun Han,[...]. Nature 2020
482
50

Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers.
Marie-Caroline Dieu-Nosjean, Nicolas A Giraldo, Hélène Kaplon, Claire Germain, Wolf Herman Fridman, Catherine Sautès-Fridman. Immunol Rev 2016
149
50

Immune contexture and histological response after neoadjuvant chemotherapy predict clinical outcome of lung cancer patients.
Romain Remark, Audrey Lupo, Marco Alifano, Jerome Biton, Hanane Ouakrim, Alessandro Stefani, Isabelle Cremer, Jeremy Goc, Jean-Francois Régnard, Marie-Caroline Dieu-Nosjean,[...]. Oncoimmunology 2016
36
50


The Immune Landscape of Cancer.
Vésteinn Thorsson, David L Gibbs, Scott D Brown, Denise Wolf, Dante S Bortone, Tai-Hsien Ou Yang, Eduard Porta-Pardo, Galen F Gao, Christopher L Plaisier, James A Eddy,[...]. Immunity 2019
96
50

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial.
Roy S Herbst, Paul Baas, Dong-Wan Kim, Enriqueta Felip, José L Pérez-Gracia, Ji-Youn Han, Julian Molina, Joo-Hang Kim, Catherine Dubos Arvis, Myung-Ju Ahn,[...]. Lancet 2016
50

The Immune Landscape of Cancer.
Vésteinn Thorsson, David L Gibbs, Scott D Brown, Denise Wolf, Dante S Bortone, Tai-Hsien Ou Yang, Eduard Porta-Pardo, Galen F Gao, Christopher L Plaisier, James A Eddy,[...]. Immunity 2018
50

Tumor immune microenvironment and immune checkpoint inhibitors in esophageal squamous cell carcinoma.
Yoshifumi Baba, Daichi Nomoto, Kazuo Okadome, Takatsugu Ishimoto, Masaaki Iwatsuki, Yuji Miyamoto, Naoya Yoshida, Hideo Baba. Cancer Sci 2020
27
50

Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC).
T R Cottrell, E D Thompson, P M Forde, J E Stein, A S Duffield, V Anagnostou, N Rekhtman, R A Anders, J D Cuda, P B Illei,[...]. Ann Oncol 2018
120
50

Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell Responses.
Nikhil S Joshi, Elliot H Akama-Garren, Yisi Lu, Da-Yae Lee, Gregory P Chang, Amy Li, Michel DuPage, Tuomas Tammela, Natanya R Kerper, Anna F Farago,[...]. Immunity 2015
207
50

Evaluation of invasive breast cancer samples using a 12-chemokine gene expression score: correlation with clinical outcomes.
Sangeetha Prabhakaran, Victoria T Rizk, Zhenjun Ma, Chia-Ho Cheng, Anders E Berglund, Dominico Coppola, Farah Khalil, James J Mulé, Hatem H Soliman. Breast Cancer Res 2017
32
50

PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups.
Lars Henning Schmidt, Andreas Kümmel, Dennis Görlich, Michael Mohr, Sebastian Bröckling, Jan Henrik Mikesch, Inga Grünewald, Alessandro Marra, Anne M Schultheis, Eva Wardelmann,[...]. PLoS One 2015
155
50

Molecular gene mutation profiles, TMB and the impact of prognosis in Caucasians and east Asian patients with lung adenocarcinoma.
Weiquan Gu, Na Wang, Weiguang Gu, Yuan Qiu, Hua Zhang, Jianmiao Liang, Tongfei Zhou, Liheng Ma, Weijing Cai, Weineng Feng,[...]. Transl Lung Cancer Res 2020
4
50

Understanding the tumor immune microenvironment (TIME) for effective therapy.
Mikhail Binnewies, Edward W Roberts, Kelly Kersten, Vincent Chan, Douglas F Fearon, Miriam Merad, Lisa M Coussens, Dmitry I Gabrilovich, Suzanne Ostrand-Rosenberg, Catherine C Hedrick,[...]. Nat Med 2018
50

B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression.
Jun Konishi, Koichi Yamazaki, Miyuki Azuma, Ichiro Kinoshita, Hirotoshi Dosaka-Akita, Masaharu Nishimura. Clin Cancer Res 2004
538
50


B-cell Receptor Recombinations in Lung Adenocarcinoma Exome Files Correlate With a Higher Overall Survival Rate.
Yaping N Tu, Wei Lue Tong, Blake M Callahan, Boris I Chobrutskiy, George Blanck. Anticancer Res 2020
1
100

PD-L1 Expression and Survival among Patients with Advanced Non-Small Cell Lung Cancer Treated with Chemotherapy.
Steffen Filskov Sorensen, Wei Zhou, Marisa Dolled-Filhart, Jeanette Baehr Georgsen, Zhen Wang, Kenneth Emancipator, Dianna Wu, Michael Busch-Sørensen, Peter Meldgaard, Henrik Hager. Transl Oncol 2016
58
50

Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells.
Jérémy Goc, Claire Germain, Thi Kim Duy Vo-Bourgais, Audrey Lupo, Christophe Klein, Samantha Knockaert, Luc de Chaisemartin, Hanane Ouakrim, Etienne Becht, Marco Alifano,[...]. Cancer Res 2014
273
50

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.
Jedd D Wolchok, Vanna Chiarion-Sileni, Rene Gonzalez, Piotr Rutkowski, Jean-Jacques Grob, C Lance Cowey, Christopher D Lao, John Wagstaff, Dirk Schadendorf, Pier F Ferrucci,[...]. N Engl J Med 2017
50

Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade.
Pornpimol Charoentong, Francesca Finotello, Mihaela Angelova, Clemens Mayer, Mirjana Efremova, Dietmar Rieder, Hubert Hackl, Zlatko Trajanoski. Cell Rep 2017
822
50

Analysis of prognostic genes in the tumor microenvironment of lung adenocarcinoma.
Zhan-Yu Xu, Mengli Zhao, Wenjie Chen, Kun Li, Fanglu Qin, Wei-Wei Xiang, Yu Sun, Jiangbo Wei, Li-Qiang Yuan, Shi-Kang Li,[...]. PeerJ 2020
8
50

Tertiary lymphoid structures improve immunotherapy and survival in melanoma.
Rita Cabrita, Martin Lauss, Adriana Sanna, Marco Donia, Mathilde Skaarup Larsen, Shamik Mitra, Iva Johansson, Bengt Phung, Katja Harbst, Johan Vallon-Christersson,[...]. Nature 2020
383
50

Implications of the tumor immune microenvironment for staging and therapeutics.
Janis M Taube, Jérôme Galon, Lynette M Sholl, Scott J Rodig, Tricia R Cottrell, Nicolas A Giraldo, Alexander S Baras, Sanjay S Patel, Robert A Anders, David L Rimm,[...]. Mod Pathol 2018
151
50


Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer.
Naiyer A Rizvi, Matthew D Hellmann, Alexandra Snyder, Pia Kvistborg, Vladimir Makarov, Jonathan J Havel, William Lee, Jianda Yuan, Phillip Wong, Teresa S Ho,[...]. Science 2015
50

In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma.
Fei Li, Qingyuan Huang, Troy A Luster, Hai Hu, Hua Zhang, Wai-Lung Ng, Alireza Khodadadi-Jamayran, Wei Wang, Ting Chen, Jiehui Deng,[...]. Cancer Discov 2020
46
50

An Immunogram for the Cancer-Immunity Cycle: Towards Personalized Immunotherapy of Lung Cancer.
Takahiro Karasaki, Kazuhiro Nagayama, Hideki Kuwano, Jun-Ichi Nitadori, Masaaki Sato, Masaki Anraku, Akihiro Hosoi, Hirokazu Matsushita, Yasuyuki Morishita, Kosuke Kashiwabara,[...]. J Thorac Oncol 2017
71
50

Global Epidemiology of Lung Cancer.
Julie A Barta, Charles A Powell, Juan P Wisnivesky. Ann Glob Health 2019
297
50


Lack of association of vitamin D receptor BsmI gene polymorphism with bone mineral density in Spanish postmenopausal women.
Jose M Moran, Maria Pedrera-Canal, Francisco J Rodriguez-Velasco, Vicente Vera, Jesus M Lavado-Garcia, Pilar Fernandez, Juan D Pedrera-Zamorano. PeerJ 2015
14
50

Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer.
Claire Germain, Sacha Gnjatic, Fella Tamzalit, Samantha Knockaert, Romain Remark, Jérémy Goc, Alice Lepelley, Etienne Becht, Sandrine Katsahian, Geoffray Bizouard,[...]. Am J Respir Crit Care Med 2014
284
50

Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers.
Aaron M Goodman, Shumei Kato, Lyudmila Bazhenova, Sandip P Patel, Garrett M Frampton, Vincent Miller, Philip J Stephens, Gregory A Daniels, Razelle Kurzrock. Mol Cancer Ther 2017
975
50

Beyond conventional immune-checkpoint inhibition - novel immunotherapies for renal cell carcinoma.
David A Braun, Ziad Bakouny, Laure Hirsch, Ronan Flippot, Eliezer M Van Allen, Catherine J Wu, Toni K Choueiri. Nat Rev Clin Oncol 2021
17
50

The association between tumor mutational burden and prognosis is dependent on treatment context.
Cristina Valero, Mark Lee, Douglas Hoen, Jingming Wang, Zaineb Nadeem, Neal Patel, Michael A Postow, Alexander N Shoushtari, George Plitas, Vinod P Balachandran,[...]. Nat Genet 2021
15
50



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.